Evidence map›Paper›PMID 29769740›Full record

ArticleNature chemical biology2018

Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP).

Christian S Lentz, Jessica R Sheldon, Lisa A Crawford, Rachel Cooper, Megan Garland, Manuel R Amieva, Eranthie Weerapana, Eric P Skaar, Matthew Bogyo

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 105 citations in OpenAlex.

  1. Unique structural and ligand-binding properties of theProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Imaging ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Unique structural and ligand binding properties of thebioRxiv : the preprint server for biology · 2025
    Article
  5. Activation of themBio · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An mRNA Display Approach for Covalent Targeting of aJournal of the American Chemical Society · 2025
    Article
  11. Article
  12. Article
  13. Diversity Oriented Clicking for Modular Synthesis.Nature reviews. Methods primers · 2025
    Article
  14. An mRNA Display Approach for Covalent Targeting of abioRxiv : the preprint server for biology · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. DecipheringmSystems · 2024
    Article
  19. Integrating the analysis of human biopsies using post-translational modifications proteomics.Protein science : a publication of the Protein Society · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Christian S LentzDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Jessica R SheldonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Lisa A CrawfordDepartment of Chemistry, Boston College, Chestnut Hill, MA, USA.
Rachel CooperDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Megan GarlandDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Manuel R AmievaDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Eranthie WeerapanaDepartment of Chemistry, Boston College, Chestnut Hill, MA, USA.
Eric P SkaarDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Matthew BogyoDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA. mbogyo@stanford.edu.ORCID http://orcid.org/0000-0003-3753-4412
Stanford University · USBoston College · USVanderbilt University Medical Center · USStanford Medicine · US

Funding

Host-mediated zinc sequestration during Acinetobacter baumannii infectionR01AI101171 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WALTER J. CHAZIN, DAVID P. GIEDROC · 2013 to 2026
$8.2M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Mechanism and function of heme-iron utilization in staphylococcal pathogenesisR01AI069233 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SKAAR, ERIC P · 2006 to 2020
$5.6M
Investigating cysteine-mediated protein activities in C. elegansR01GM118431 · NIGMS · BOSTON COLLEGE · PI WEERAPANA, ERANTHIE · 2015 to 2019
$1.8M
Equipment supplement for Chemical methods to study protein palmitoylation pathwaysR01GM111703 · NIGMS · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2014 to 2017
$1.6M
Investigating cysteine PTMs in living cellsR01GM117004 · NIGMS · BOSTON COLLEGE · PI WEERAPANA, ERANTHIE · 2016 to 2019
$1.2M
Role of novel adherens junction proteins in susceptibility to S. aureus alpha-toxinR21AI117255 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R · 2016 to 2017
$442k
NIAID NIH HHS R01 AI069233NIAID NIH HHS R01 AI101171NIAID NIH HHS R21 AI117255NIGMS NIH HHS R01 GM111703NIGMS NIH HHS R01 GM117004NIGMS NIH HHS R01 GM118431NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Serine hydrolases play diverse roles in regulating host-pathogen interactions in a number of organisms, yet few have been characterized in the human pathogen Staphylococcus aureus. Here we describe a chemical proteomic screen that identified ten previously uncharacterized S. aureus serine hydrolases that mostly lack human homologs. We termed these enzymes fluorophosphonate-binding hydrolases (FphA-J). One hydrolase, FphB, can process short fatty acid esters, exhibits increased activity in response to host cell factors, is located predominantly on the bacterial cell surface in a subset of cells, and is concentrated in the division septum. Genetic disruption of fphB confirmed that the enzyme is dispensable for bacterial growth in culture but crucial for establishing infection in distinct sites in vivo. A selective small molecule inhibitor of FphB effectively reduced infectivity in vivo, suggesting that it may be a viable therapeutic target for the treatment or management of Staphylococcus infections.

Indexed as

AnimalsAnti-Bacterial AgentsBacterial ProteinsBinding SitesCloning, MolecularFatty AcidsGenetic TechniquesHEK293 CellsHost-Pathogen InteractionsHumansHydrolasesHydrolysisKineticsMiceMicrobial Sensitivity TestsOrganophosphonatesAnti-Bacterial AgentsBacterial ProteinsFatty AcidsHydrolasesOrganophosphonatesSerineVirulence Factors

Identifiers

PMID29769740
PMCPMC6202179
OpenAlexW2803685741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.